Search Results - "FEDEROWICZ, I"

Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study by Van Cutsem, E, Li, C-P, Nowara, E, Aprile, G, Moore, M, Federowicz, I, Van Laethem, J-L, Hsu, C, Tham, C K, Stemmer, S M, Lipp, R, Zeaiter, A, Fittipaldo, A, Csutor, Z, Klughammer, B, Meng, X, Ciuleanu, T

“…Background: This phase II, open-label, randomised study evaluated whether patients with metastatic pancreatic cancer receiving erlotinib/gemcitabine derived…”
Get full text

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant by NASILOWSKA-ADAMSKA, B, RZEPECKI, P, DUDA, D, SZYDLO, R, HALABURDA, K, SZCZEPINSKI, A, LANGE, A, HELLMAN, A, ROBAK, T, SKOTNICKI, A, JEDRZEJCZAK, W. W, WALEWSKI, J, MANKO, J, HOLOWIECKI, J, KOMARNICKI, M, DMOSZYNSKA, A, WARZOCHA, K, MARIANSKA, B, CZYZ, A, MARKIEWICZ, M, FEDEROWICZ, I, TOMASZEWSKA, A, PIATKOWSKA-JAKUBAS, B, WRZESIEN-KUS, A, BIENIASZEWSKA, M

“…In this multicenter study, we assessed the use of palifermin (recombinant human-keratinocyte growth factor 1) in the prevention of oral mucositis (OM) and…”
Get full text

Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage by Federowicz, I, Barrett, B B, Andersen, J W, Urashima, M, Popovsky, M A, Anderson, K C

“…During the storage of cellular components before transfusion, cytokines that may mediate transfusion reactions are released from white cells (WBCs). Adverse…”
Get more information

90Y-Zevalin® (90Y-Ibritumomab Tiuxetan) Radioimmunotherapy (RIT) Consolidation of FCM Induction Chemotherapy in Mantle Cell Lymphoma (MCL) Patients: Results from the PLRG upon Completed Enrollment by Jurczak, Wojciech, Giza, A., Szostek, M., Hubalewska-Dydejczyk, A., Sowa-Staszczak, A., Knopinska-Posluszny, W., Hellmann, A., Zdziarska, B., Wrobel, T., Krycz-Krzemien, S., Poplawska, L., Federowicz, I., Walewski, Jan, Skotnicki, Aleksander

“…Background: The 5-yr survival rate is <20% for MCL. Standard chemotherapy for MCL includes fludarabine, cyclophosphamide, and mitoxantrone (FCM). Adding…”
Get full text

PCN44 COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCERTREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING by Kawalec, P, Szawlowski, A, Federowicz, I, Szkultecka-Debek, M, Russel-Szymczyk, M

Get full text

Randomized Comparison of Cladribine Single (C) or in Combination with Cyclophosphamide (CC), and COP in Previously Untreated Low Grade B-Cell Non-Hodgkin Lymphoma Patients by Kalinka, E., Wajs, J., Sulek, K.S., Blasinska-Morawiec, M., Centkowski, P., Ceglarek, B., Robak, T., Holowiecki, J., Mazur, G., Federowicz, I., Jedrzejczak, W., Watek, M., Warzocha, K.

“…To comparatively assess first-line treatment with cladribine single (C) or in combination with cyclophosphamide (CC), and COP (cyclophosphamide, vincristine,…”
Get full text

Evaluation of humoral response to trivalent influenza vaccination in patients with non-Hodgkin lymphoma (NHL) previously treated or untreated with chemotherapy by Warzocha, K., Centkowski, P., Brydak, L. B., Machała, M., Kalinka, E., Błasińska-Morawiec, M., Wȩgrzyn, J., Sawczuk-Chabin, J., Federowicz, I., Walewski, J.

“…Abstract only…”
Get full text

Prolymphocytic leukemia by Nowosielski, J, Federowicz, I

Get more information

A case of prolymphocytic leukemia by Federowicz, I, Sułek, K, Mielcarek, W

Get more information

Successful autologous transplantation of circulating hematopoietic stem cells in acute myeloblastic leukemia by Sułek, K, Kłos, M, Federowicz, I, Jarczewska, M, Nowak, J, Carewicz, R, Nowosielski, J

Get more information

Bone marrow transplantation after preoperative chemotherapy and total body irradiation. III. Case report by Sułek, K, Kłos, M, Jarczewska, M, Federowicz, I, Nowak, J, Carewicz, R, Dańczak-Ginalska, Z, Meder, J, Kukołowicz, P, Czermińska, M

Get more information